The Appropriateness Method
Paul Shekelle I n this issue of Medical Decision Making, Taffé and colleagues describe a study of the clinical and economic factors influencing the assessments of appropriateness made by clinicians as part of an application of the RAND-UCLA appropriateness method for assessing the use of preoperative erythropoietin in elective orthopedic surgery. 1 Since some readers of the journal may not be familiar with the appropriateness method, in this space I will discuss the development of the appropriateness method, how it is applied, and some of what is known about its utility and validity.
The appropriateness method was developed as a pragmatic solution to the problem of trying to assess for what patients certain surgical and medical procedures are "appropriate." In this context, appropriate means that the benefits sufficiently exceed the risks and that the procedure is worth doing. Twenty years ago, descriptions of geographic variations in the use of procedures were achieving widespread visibility, and a hypothesis of the time was that any rate of use higher than the lowest identified rate probably represented "inappropriate" overuse of the procedure at the higher use sites. Investigators at RAND and UCLA set out to test this hypothesis hoping to compare the rate of appropriate and inappropriate use at high-and low-use geographic sites, assuming that the determination of what is appropriate use for a procedure could be made from a thorough review of the medical literature. Having been disabused of this notion after examining the literature on 6 procedures, the investigators were left with the problem of how to make such assessments.
Several fundamental concepts helped shape their solution:
• The medical literature alone is insufficient to make judgments about appropriateness for most potential indications for any procedure. Clinical judgment would be required to "fill in the gaps." • All the clinical disciplines involved in the care of a certain condition have something to contribute to the determination of appropriateness. The clinical input should come from a multidisciplinary group.
• The method should produce results that are "decidable" and not use "weasel words." The indications must be described in sufficient clinical detail so that each description is relatively homogenous with respect to risks and benefits of the procedure and can be labeled as appropriate or not.
• The results should be comprehensive and applicable to most clinical situations for which a patient may seek or be offered the procedure. Ergo, a very large number of clinical situations would need to be considered.
• Applying the method must be feasible in terms of resources.
With these concepts in mind, and incorporating elements of established group process methods such as the Delphi and the nominal group technique, the investigators developed what is known today as the RAND-UCLA appropriateness method. The original method used a 9-member mixed panel of clinical specialists, and this has been broadened to panels with as few as 6 and as many as 15 members. The panel members are provided with a state-of-the-art literature review regarding what is known and not known about the risks and benefits of the procedure. They are asked to rate, on a 9-point scale with 1 being lowest and 9 being highest, the appropriateness of performing the procedure for a comprehensive set of specific clinical circumstances or clinical scenarios. Because of the need for comprehensiveness, in most cases, panelists are asked to rate for appropriateness many hundreds of different specific clinical circumstances. Appropriateness is defined as meaning "the health benefits exceed the health risks by a sufficiently wide margin that the procedure is worth doing." A rating of 5 means that the risks and benefits are about equal. Panel members are asked to use the clinical literature plus their best clinical judgment to assess the appropriateness of performing the procedure by an average clinician. Note that they are not asked to rate performance by the best clinician, such as the physicians that may be preferentially re-cruited to participate in clinical trials. Panelists are further given a set of specific definitions for any terms with potentially ambiguous definitions; terms such as a positive exercise treadmill test or having failed medical therapy are given precise definitions. This is done for 2 reasons: first, so that all the panelists are making their decisions from the same frame of reference, and second, so that the results can be applied to real cases in a reproducible manner.
Panelists rate for appropriateness the list of clinical scenarios twice, before and after a group meeting. The 1st round ratings are returned to the panelists at the panel meeting. Thus, for each scenario, the panelist can see what the group ratings were and also an indication of what his or her own rating was (this is the Delphi component). The panel is then led by a moderator through the definitions and scenarios, discussing each in turn. The definitions can be changed by the panel to better fit their clinical judgment. The discussion of the scenarios is concentrated on those for which there was a wide range of ratings on the 1st round. Such disagreement usually stems from 1 of 3 sources: (1) the definitions of clinical terms were not clear or not understood by all panel members, (2) there are new studies about which only some panel members are aware, and (3) there is disagreement among panelists about the interpretation of the studies and/or their own clinical experience. The moderator seeks to resolve differences in the first 2 circumstances while not seeking to force agreement on the third.
The 2nd, final ratings are used for the analysis. The 1st determination is whether the panel disagreed about the rating for a specific scenario. Different definitions have been proposed and used for disagreement, but the most commonly used definition (for a 9-member panel) is 3 panelists rating a scenario in the lowest tertile of appropriateness (1-2-3) and three panelists rating the same scenario in the upper tertile (7-8-9) . All scenarios for which there is disagreement are classified as of "uncertain" appropriateness. This is usually less than 5% of all scenarios. In the absence of disagreement, the median panel rating is used to make the classification. Median panel ratings in the lowest tertile are classified as inappropriate, those in the upper tertile are classified as appropriate, and those whose median rating is 4-5-6 are (along with all for which there is disagreement) classified as uncertain. An additional step is sometimes taken, using a 3rd round of ratings, to further divide the appropriate scenarios into those that are "necessary," meaning that it would be improper care to not offer the procedure, and "appropriate but not necessary," meaning that it is acceptable to perform the procedure but not improper to not perform it. Analyses in research studies frequently assess only the extremes of these scales, those cases that are classified as inappropriate (for procedures that were delivered but should not have been) and those classified as necessary who were not offered the procedure (for procedures that should have been delivered but were not).
Given the somewhat arbitrary nature of key elements of the method and the global implicit nature of the decision-making process, it is no surprise that the appropriateness method has been viewed with considerable suspicion by many observers. [2] [3] [4] These critiques have centered on the potential variability in the process due to the composition of the panel or the actual panel members themselves, the role of the moderator, the possibility of misclassification bias of individual scenarios, a lack of specificity about what outcomes are being considered for individual scenarios, and worry that the ratings reflect nothing more than codifying existing clinical dogma. A substantial amount of methodologic research has been done to try to assess these concerns. What is known is that the results are very sensitive to the composition of the panel, in that clinicians who perform the procedure are more enthusiastic about its use. 5 If composition in terms of disciplines is held constant, the results are about as reproducible as some common diagnostic tests, with a kappa of about 0.5 to 0.7 between similarly composed panels considering the same procedures. 6, 7 Studies of testretest reliability with the same panelists have yielded a correlation coefficient exceeding 0.9. 8 The potential variability due to the moderator has never been assessed. Studies assessing content and construct validity have yielded favorable assessments. 8 However, for many observers, it is studies of predictive validity that matter most. Studies have reported favorable predictive validity for appropriateness ratings of the use of coronary angiography, 9,10 carotid endarterectomy, 11 and coronary revascularization. 12, 13 In one prospective study, a strong graded relationship was found between appropriateness score and mortality in patients eligible for coronary artery bypass grafting. 13 The results of this study suggested that a survival benefit extended into patients rated 6 (and therefore "uncertain"), a finding compatible with a comparison of appropriateness ratings and decision analysis for carotid endarterectomy that reported overall good rank order agreement between the 2 methods but that decision analysis tended to produce slightly more favorable estimates of net benefit than did appropriateness ratings.
14 Other studies comparing the results of appropriateness method panels to decision analysis have reported mixed results. 15, 16 The sensitivity and specificity of the method to identify inappropriate overuse and underuse has been estimated at varying between 68% and 99% and 94% and 97%, respectively. 17 These favorable results notwithstanding, the global implicit nature of the decision-making process leaves some observers uncomfortable since it strikes them as akin to a "black box" approach to medical decision making. The work reported in this issue by Taffé and colleagues goes some way toward trying to shine light in the black box by using regression analysis to discern the clinical factors most responsible for the results. Their findings that certain clinical factors can explain much of the variance confirms similar findings reported for coronary angiography 18 and carotid endortectomy. 8 The authors' work also highlights the importance of the need to precisely define for the panel the "outcome" they are to be using when assessing appropriateness. In most applications of the appropriateness method, panelists are told explicitly to ignore costs when making decisions about appropriateness (this was originally done to avoid having different classifications of appropriateness for the same clinical presentation based purely on the ability to pay). In the application reported by Taffé and colleagues, panelists rated appropriateness twice, in 1 case using only clinical features and in the 2nd adding in economic and resource constraints. In the latter case, appropriateness for individuals decreased compared to benefits for a population (more appropriate use of resources elsewhere). These data support my hypothesis for why we observed better reproducibility among multiple panels assessing the appropriateness of coronary revascularization than among panels assessing elective hysterectomy. In the former circumstance, the panel members were all considering mortality as a (well-defined) outcome whereas in the latter, they were considering quality of life (at the time ill defined for this patient population). I am of the belief that much more could be done to make the outcomes being considered more explicit in applications of the appropriateness method.
So, where to from here? I believe that although the current method is very useful both as a research tool and as an aid to clinical decision making and that wider clinical use of the appropriateness method would lead to better clinical outcomes, the appropriateness method could be greatly improved. I believe improvements should come in 4 areas. The 1st of these deals with improving the definition of the outcome. As it stands now, the outcome is global and implicit. Separating this into health states and patient utilities for the health states would likely improve both the reproducibility of the method and the usefulness of the results for decision making. Patients could tailor appropriateness ratings using their own health state utilities. The methods of decision analysis could be usefully incorporated into the appropriateness method. The 3 additional improvements I envision all involve the recent vast expansion of our information technology systems. First, I believe new analyses of clinically detailed observational databases that can relate clinical features, treatments, and patient outcomes can be used to improve the evidence on which to make decisions about appropriateness. Our experience has been that the clinical trial and existing observational studies use inclusion/exclusion criteria that are not as sufficiently detailed as the clinical scenarios created by clinicians to describe groups of patients clinically homogenous with respect to appropriateness, and the richer data available in some observational databases could be used to supplement existing clinical trial data. The insights obtained from analysis of the Duke cardiovascular database are examples of what I would envision for all of the major procedures. 19 Second, I believe that the process of conducting the appropriateness method could be greatly improved by making the whole process possible on computers, with the ability to instantly revise indications online and instantly analyze ratings, allowing many more panelists to participate and permitting multiple rounds of ratings as needed for certain indications. I have personally participated in several applications in which the 1st-round ratings have been performed online, and it would seem to me that the groups doing these should collaborate to produce one full-scale paperless real time implementation rather than disperse their limited resources in separate attempts. It may be possible to do updates completely over the Internet, with no need for an in-person panel meeting, 20 and I can envision a process of annual or quarterly updates to keep appropriateness criteria current with recent evidence. Third, the clinical application of appropriateness criteria is greatly impeded at present since they are presented in a manner that is nearly impenetrable to clinicians. Building appropriateness criteria into clinical decision support systems that are themselves embedded in electronic health records offers the prospect of greatly improving the clinical usefulness of these tools.
